Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.54% |
| 2 | Technology | 10.66% |
| 3 | Financials | 10.63% |
| 4 | Consumer Discretionary | 9.38% |
| 5 | Industrials | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
CALL
Accenture
ACN
$106B
| $510K | ﹤0.01% |
+2,900
| New | +$456K |
|
|
3227
PUT
Accenture
ACN
$106B
| $510K | ﹤0.01% |
+2,900
| New | +$456K |
|
|
LX
3228
LexinFintech Holdings
LX
$246M
| $510K | ﹤0.01% |
+48,600
| New | +$495K |
|
3229
AudioCodes
AUDC
$239M
| $508K | ﹤0.01% |
36,677
-259,659
| -88% | -$3.42M |
|
3230
Fastenal
FAST
$54.8B
| $506K | ﹤0.01% |
31,488
-3,331,604
| -99% | -$50.1M |
|
3231
TransDigm Group
TDG
$70.7B
| $506K | ﹤0.01% |
+1,114
| New | +$452K |
|
|
CHSP
3232
DELISTED
Chesapeake Lodging Trust
CHSP
| $506K | ﹤0.01% |
18,191
-3,365
| -16% | -$94.9K |
|
|
EVN
3233
Eaton Vance Municipal Income Trust
EVN
$417M
| $505K | ﹤0.01% |
+41,400
| New | +$486K |
|
3234
Genesco
GCO
$434M
| $505K | ﹤0.01% |
11,087
-27,373
| -71% | -$1.25M |
|
3235
Innovative Industrial Properties
IIPR
$1.77B
| $505K | ﹤0.01% |
+6,186
| New | +$418K |
|
3236
iShares International Select Dividend ETF
IDV
$8.31B
| $503K | ﹤0.01% |
16,300
-11,691
| -42% | -$361K |
|
|
MRSN
3237
DELISTED
Mersana Therapeutics
MRSN
| $503K | ﹤0.01% |
3,829
+2,059
| +116% | +$259K |
|
3238
Annaly Capital Management
NLY
$17.3B
| $503K | ﹤0.01% |
+12,600
| New | +$514K |
|
3239
CALL
AT&T
T
$164B
| $502K | ﹤0.01% |
+21,184
| New | +$487K |
|
|
3240
PUT
AT&T
T
$164B
| $502K | ﹤0.01% |
+21,184
| New | +$487K |
|
|
NTUS
3241
DELISTED
Natus Medical Inc
NTUS
| $502K | ﹤0.01% |
+19,777
| New | +$590K |
|
|
QHC
3242
DELISTED
Quorum Health Corporation
QHC
| $502K | ﹤0.01% |
+358,511
| New | +$965K |
|
3243
ANI Pharmaceuticals
ANIP
$1.86B
| $500K | ﹤0.01% |
7,085
-3,746
| -35% | -$220K |
|
|
TVRD
3244
Tvardi Therapeutics
TVRD
$20.1M
| $500K | ﹤0.01% |
708
-8,024
| -92% | -$4.8M |
|
3245
Lifecore Biomedical
LFCR
$162M
| $499K | ﹤0.01% |
+40,671
| New | +$497K |
|
|
NHS
3246
Neuberger High Yield Strategies Fund Inc
NHS
$250M
| $499K | ﹤0.01% |
+44,200
| New | +$480K |
|
|
TTM
3247
DELISTED
Tata Motors Limited
TTM
| $499K | ﹤0.01% |
+39,715
| New | +$496K |
|
3248
Vanguard Financials ETF
VFH
$13.4B
| $495K | ﹤0.01% |
7,669
-920
| -11% | -$59.7K |
|
|
SRNE
3249
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $495K | ﹤0.01% |
+104,217
| New | +$273K |
|
|
TGH
3250
DELISTED
Textainer Group Holdings limited
TGH
| $494K | ﹤0.01% |
51,150
+35,297
| +223% | +$419K |
|
Similar funds
Millennium Management's Q1 2019 Portfolio in Review
As of Q1 2019, Millennium Management held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Millennium Management withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, Millennium Management opened a new position in Zimmer Biomet worth $232M.
- Millennium Management's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Millennium Management added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Millennium Management's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Millennium Management fully exited Merck in Q1 2019, selling an estimated $375M.
- Millennium Management's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Millennium Management opened 914 new positions and closed 675 in Q1 2019.
- Millennium Management's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.